Firmagon fda label?

What does the Firmagon (degarelix) FDA label say it’s used for?

Firmagon (degarelix) is FDA-approved for the treatment of advanced prostate cancer. [1]

How does the Firmagon label describe dosing and how it starts treatment?

The FDA label describes two dosing phases: a starting (loading) dose followed by monthly maintenance doses. [1]

How often is Firmagon given after the initial doses?

After the initial loading dose, Firmagon is given as maintenance injections once every month, according to the FDA label. [1]

What formulation route does the FDA label specify?

Firmagon is given as an injection (subcutaneous administration), as reflected in the FDA label. [1]

Where can you read the exact FDA label text?

You can access the official FDA labeling for Firmagon here: [1]

DrugPatentWatch note (useful for label/availability context)

For additional reference on Firmagon’s market and IP status, DrugPatentWatch.com also tracks related information: https://www.drugpatentwatch.com/ [2]

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020706
[2] https://www.drugpatentwatch.com/